medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number S2

<< Back Next >>

Arch Cardiol Mex 2006; 76 (S2)

Physiopathogenesis of hypertension

Vargas AG
Full text How to cite this article

Language: Spanish
References: 21
Page: 157-160
PDF size: 84.00 Kb.


Key words:

Cardiovascular diseases, Genetics, Hypertension, Inflammation, Metabolic syndrome.

ABSTRACT

Arterial hypertension is one of major cardiovascular risk factors in the world. Many pathophysiologic factors have been implicated in the genesis of hypertension such as increased sympathetic nervous system activity, overproduction of sodium-retaining hormones and vasoconstrictors, increased or inappropriate renin secretion with resultant increased production of angiotensin II and aldosterone, deficiencies of vasodilators, vascular reactivity, vascular remodeling, production of inflammatory molecules and endothelial dysfunction. On the other hand, the hereditary nature of this disease has been well established in many familial studies The quantitative contribution of genetic factors to blood pressure variance is estimated to be about 30%.


REFERENCES

  1. VELAZQUEZ-MONROY O, ROSAS-PERALTA M, LARAESQUEDA A, PASTELIN-HERNÁNDEZ G, ATTIE F, TAPIA-CONVER R; Grupo Encuesta Nacional de Salud 2000: Arterial hypertension in Mexico: results of the National Health Survey 2000. Arch Cardiol Mex 2002; 72: 71-84.

  2. BROOK RD, JULIUS S: Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13: 112-122.

  3. MARK AL: The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 1996; 14: S159-S165.

  4. FOLKOW B: Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504.

  5. VANHOTTE PM, EBER B: Endothelium-derived relaxing and contracting factors. Wiener Klin. Wochenschrift 1991; 14: 405-411.

  6. CAREY RM, SIRAGY HM: Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24: 261-271.

  7. GRIFFIN SA, BROWN WC, MACPHERSON F, MCGRATH JC, WILSON VG, KORSGAARD N, ET AL: Angiotensin II causes vascular hypertrophy in part by a non pressor mechanism. Hypertens 1991; 17: 626-635.

  8. CHAE CU, LEE RT, RIFAI N, RIDKER PM: Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.

  9. STAESSEN JA, WANG J, BIANCHI G, BIRKENHAGER WH: Essential hypertension. Lancet 2003;

  10. 361:1629-1641.

  11. RIEDER MJ, TAYLOR SL, CLARK AG, NICKERSON DA: Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999; 22: 59-62.

  12. STAESSEN JA, WANG JG, GINOCCHIO G, PETROV V, SAAVEDRA AP, SOUBRIER F, ET AL: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579-1592.

  13. WILLIAMS SM, RITCHIE MD, PHILLIPS JA 3RD, DAWSON E, PRINCE M, DZHURA E, ET AL: Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004; 57: 28-38.

  14. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, ET AL: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.

  15. STAESSEN JA, KUZNETSOVA T, WANG JG, EMELIANOV D, VLIETINCK R, FAGARD R: M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17:9-17.

  16. KATO N, SUGIYAMA T, MORITA H, KURIHARA H, YAMORI Y, YAZAKI Y: Angiotensinogen gene and essential hypertension in the japanese. Extensive association study and meta-analysis on six reported studies. J Hypertens 1999; 17: 757-763.

  17. BAUDIN B: Polymorphism in angiotensin II receptor genes and hypertension. Exp Physiol 2005; 90: 277-282.

  18. MATSUBARA M, SATO T, NISHIMURA T, SUZUKI M, KIKUYA M, METOKI H, ET AL: CYPIIB2 polymorphism and home blood pressure in a populationbased cohort in japanese: the Ohasama study. Hypertens Res 2004; 27: 1-6.

  19. BAUTISTA LE, VERA LM, ARENAS IA, GAMARRA G: Independent association between inflammatory markers (C-reactive protein, interleukin 6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005; 19: 149-154.

  20. TANAKA C, MANNAMI T, KAMIDE K, TAKIUCHI S, KOKUBO Y, KATSUVA T, ET AL: Single nucleotide polymorphisms in the interleukin 6 gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 2005; 28: 35-41.

  21. SHIOJI K, KOKUBO Y, MANNAMI T, INAMOTO N, MORISAKI H, MINO Y, ET AL: Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 2004; 27: 31-37.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2006;76